Metraipolis › archive › dc_a68fe6d7db99
Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and… — Europe PMC PMID:42433378
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42433378
- DOI
- 10.3389/fimmu.2026.1840292
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T16:58:24.007Z
- SHA-256 of the archived text
a4753dcefb2561219eb30b84ea6f92caeb95b2f2eef0c51de30bab2cff54f5bb- Stable URL of this page
https://metraipolis.com/documento/dc_a68fe6d7db99
How to cite
Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and… — Europe PMC PMID:42433378 — Europe PMC (en), https://europepmc.org/article/MED/42433378 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a68fe6d7db99 (Metraipolis archive dc_a68fe6d7db99, sha256 a4753dcefb2561219eb30b84ea6f92caeb95b2f2eef0c51de30bab2cff54f5bb)
BibTeX
@misc{dca68fe6d7db99,
title = {Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and… — Europe PMC PMID:42433378},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42433378},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a68fe6d7db99; sha256 a4753dcefb2561219eb30b84ea6f92caeb95b2f2eef0c51de30bab2cff54f5bb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42433378. Agents can read the archived copy with the MCP tool read_document.